AAAAAA
Results: 1-25/40
Authors:
Lev, N
Maimon, S
Rappaport, ZH
Melamed, E
Citation: N. Lev et al., Spinal dural arteriovenous fistulae - A diagnostic challenge, ISR MED ASS, 3(7), 2001, pp. 492-496
Authors:
Wangberg, I
Munthe, J
Pirrone, N
Iverfeldt, A
Bahlman, E
Costa, P
Ebinghaus, R
Feng, X
Ferrara, R
Gardfeldt, K
Kock, H
Lanzillotta, E
Mamane, Y
Mas, F
Melamed, E
Osnat, Y
Prestbo, E
Sommar, J
Schmolke, S
Spain, G
Sprovieri, F
Tuncel, G
Citation: I. Wangberg et al., Atmospheric mercury distribution in Northern Europe and in the Mediterranean region, ATMOS ENVIR, 35(17), 2001, pp. 3019-3025
Authors:
Albanese, A
Bonuccelli, U
Brefel, C
Chaudhuri, KR
Colosimo, C
Eichhorn, T
Melamed, E
Pollak, P
Van Laar, T
Zappia, M
Citation: A. Albanese et al., Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease, MOVEMENT D, 16(2), 2001, pp. 197-201
Authors:
Djaldetti, R
Melamed, E
Gadoth, N
Citation: R. Djaldetti et al., Abnormal skin wrinkling in the less affected side in hemiparkinsonism - a possible test for sympathetic dysfunction in Parkinson's disease, BIOMED PHAR, 55(8), 2001, pp. 475-478
Authors:
Djaldetti, R
Rosmarin, V
Ziv, I
Melamed, E
Citation: R. Djaldetti et al., The pharmacokinetic profile of the "first ever" oral dose of levodopa in de novo patients with Parkinson's disease, CLIN NEUROP, 24(2), 2001, pp. 95-98
Authors:
Offen, D
Panet, H
Galili-Mosberg, R
Melamed, E
Citation: D. Offen et al., Catechol-O-methyltransferase decreases levodopa toxicity in vitro, CLIN NEUROP, 24(1), 2001, pp. 27-30
Authors:
Djaldetti, R
Melamed, E
Citation: R. Djaldetti et E. Melamed, New therapies for Parkinson's disease, J NEUROL, 248(5), 2001, pp. 357-362
Authors:
Barzilai, A
Melamed, E
Shirvan, A
Citation: A. Barzilai et al., Is there a rationale for neuroprotection against dopamine toxicity in Parkinson's disease?, CELL MOL N, 21(3), 2001, pp. 215-235
Authors:
Gilgun-Sherki, Y
Melamed, E
Offen, D
Citation: Y. Gilgun-sherki et al., Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier, NEUROPHARM, 40(8), 2001, pp. 959-975
Authors:
Panet, H
Barzilai, A
Daily, D
Melamed, E
Offen, D
Citation: H. Panet et al., Activation of nuclear transcription factor kappa B (NF-kappa B) is essential for dopamine-induced apoptosis in PC12 cells, J NEUROCHEM, 77(2), 2001, pp. 391-398
Authors:
Daily, D
Vlamis-Gardikas, A
Offen, D
Mittelman, L
Melamed, E
Holmgren, A
Barzilai, A
Citation: D. Daily et al., Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by dual activation of the Ras-phosphoinositide 3-kinase and jun N-terminal kinase pathways, J BIOL CHEM, 276(24), 2001, pp. 21618-21626
Authors:
Daily, D
Vlamis-Gardikas, A
Offen, D
Mittelman, L
Melamed, E
Holmgren, A
Barzilai, A
Citation: D. Daily et al., Glutaredoxin protects cerebellar granule neurons from dopamine-induced apoptosis by activating NF-kappa B via Ref-1, J BIOL CHEM, 276(2), 2001, pp. 1335-1344
Authors:
Ziv, I
Shirvan, A
Offen, D
Barzilai, A
Melamed, E
Citation: I. Ziv et al., Molecular biology of dopamine-induced apoptosis - Possible implications for Parkinson's disease, METH MOL M, 62, 2001, pp. 73-87
Authors:
Giladi, N
Melamed, E
Citation: N. Giladi et E. Melamed, The role of functional neurosurgery in Parkinson's disease, ISR MED ASS, 2(6), 2000, pp. 455-461
Authors:
Offen, D
Kaye, JF
Bernard, O
Merims, D
Coire, CI
Panet, H
Melamed, E
Ben-Nun, A
Citation: D. Offen et al., Mice overexpressing bcl-2 in their neurons are resistant to myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis (EAE), J MOL NEURO, 15(3), 2000, pp. 167-176
Authors:
Merims, D
Galili-Mosberg, R
Melamed, E
Citation: D. Merims et al., Is there addiction to levodopa in patients with Parkinson's disease?, MOVEMENT D, 15(5), 2000, pp. 1014-1016
Authors:
Rudnick, A
Ezra, Y
Melamed, E
Citation: A. Rudnick et al., Breaking bad news and personality assessment, PAT EDUC C, 41(2), 2000, pp. 157-160
Authors:
Rabey, JM
Sagi, I
Huberman, M
Melamed, E
Korczyn, A
Giladi, N
Inzelberg, R
Djaldetti, R
Klein, C
Berecz, G
Citation: Jm. Rabey et al., Rasagiline mesylate, a new MAO-B inhibitor for the treatment of Parkinson's disease: A double-blind study as adjunctive therapy to levodopa, CLIN NEUROP, 23(6), 2000, pp. 324-330
Authors:
Melamed, E
Offen, D
Shirvan, A
Ziv, I
Citation: E. Melamed et al., Levodopa - an exotoxin or a therapeutic drug?, J NEUROL, 247, 2000, pp. 135-139
Authors:
Offen, D
Elkon, H
Melamed, E
Citation: D. Offen et al., Apoptosis as a general cell death pathway in neurodegenerative diseases, J NEUR TR-S, (58), 2000, pp. 153-166
Authors:
Galili-Mosberg, R
Gil-Ad, I
Weizman, A
Melamed, E
Offen, D
Citation: R. Galili-mosberg et al., Haloperidol - induced neurotoxicity - possible implications for tardive dyskinesia, J NEURAL TR, 107(4), 2000, pp. 479-490
Authors:
Shirvan, A
Shina, R
Ziv, I
Melamed, E
Barzilai, A
Citation: A. Shirvan et al., Induction of neuronal apoptosis by Semaphorin3A-derived peptide, MOL BRAIN R, 83(1-2), 2000, pp. 81-93
Authors:
Hochman, A
Liang, HY
Offen, D
Melamed, E
Sternin, H
Citation: A. Hochman et al., Developmental changes it antioxidant enzymes and oxidative damage in kidneys, liver and brain of bcl-2 knockout mice, CELL MOL B, 46(1), 2000, pp. 41-52
Authors:
Zilkha-Falb, R
Barzilai, A
Djaldeti, R
Ziv, I
Melamed, E
Shirvan, A
Citation: R. Zilkha-falb et al., Involvement of T-complex protein-1 delta in dopamine triggered apoptosis in chick embryo sympathetic neurons, J BIOL CHEM, 275(46), 2000, pp. 36380-36387
Authors:
Offen, D
Sherki, Y
Melamed, E
Fridkin, M
Brenneman, DE
Gozes, I
Citation: D. Offen et al., Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease, BRAIN RES, 854(1-2), 2000, pp. 257-262